Evidence map›Paper›PMID 29101016›Full record

ArticleActa biomaterialia2018

Synthesis and evaluation of dual crosslinked alginate microbeads.

Sami I Somo, Kelly Langert, Chin-Yu Yang, Marcella K Vaicik, Veronica Ibarra, Alyssa A Appel, Banu Akar, Ming-Huei Cheng, Eric M Brey

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Acta biomaterialia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in bioengineering and biotechnology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Biomaterial-Assisted Regenerative Medicine.International journal of molecular sciences · 2021
    Review
  13. Article
  14. Alginate Hydrogels with Tuneable Properties.Advances in biochemical engineering/biotechnology · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Sami I SomoDepartment of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA; Research Service, Edward Hines, Jr. VA. Hospital, Hines, IL, USA.
Kelly LangertDepartment of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA; Research Service, Edward Hines, Jr. VA. Hospital, Hines, IL, USA.
Chin-Yu YangCenter for Tissue Engineering, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Marcella K VaicikDepartment of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA; Research Service, Edward Hines, Jr. VA. Hospital, Hines, IL, USA.
Veronica IbarraDepartment of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.
Alyssa A AppelDepartment of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.
Banu AkarDepartment of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA; Research Service, Edward Hines, Jr. VA. Hospital, Hines, IL, USA.
Ming-Huei ChengCenter for Tissue Engineering, Chang Gung Memorial Hospital, Taoyuan, Taiwan. Electronic address: minghuei@cgmh.org.tw.
Eric M BreyDepartment of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA; Research Service, Audie L. Murphy Memorial VA Hospital, San Antonio, TX, USA; Department of Biomedical Engineering, University of Texas at San Antonio, San Antonio, TX, USA.
Illinois Institute of Technology · USChang Gung Memorial Hospital · TW

Funding

AN ENABLING TECHNOLOGY FOR PRECLINICAL X-RAY IMAGING OF BIOMATERIALS IN-VIVOR01EB020604 · NIBIB · WASHINGTON UNIVERSITY · PI ANASTASIO, MARK A, BREY, ERIC M · 2016 to 2019
$2.3M
Synthetic Matrices for Vascularization of Engineered TissuesI01BX000418 · VA · EDWARD HINES JR VA HOSPITAL · PI BREY, ERIC M · 2010 to 2017
–
PLGA Nanoparticles as a Localized Therapy for Experimental Autoimmune Neuritis?IK2RX002305 · VA · EDWARD HINES JR VA HOSPITAL · PI LANGERT, KELLY A · 2017 to 2021
–
BLRD VA I01 BX000418NIBIB NIH HHS R01 EB020604RRD VA IK2 RX002305
6 · The paper itself

Abstract

Alginate hydrogels have been investigated for a broad variety of medical applications. The ability to assemble hydrogels at neutral pH and mild temperatures makes alginate a popular choice for the encapsulation and delivery of cells and proteins. Alginate has been studied extensively for the delivery of islets as a treatment for type 1 diabetes. However, poor stability of the encapsulation systems after implantation remains a challenge. In this paper, alginate was modified with 2-aminoethyl methacrylate hydrochloride (AEMA) to introduce groups that can be photoactivated to generate covalent bonds. This enabled formation of dual crosslinked structure upon exposure to ultraviolet light following initial ionic crosslinking into bead structures. The degree of methacrylation was varied and in vitro stability, long term swelling, and cell viability examined. At low levels of the methacrylation, the beads could be formed by first ionic crosslinks followed by exposure to ultraviolet light to generate covalent bonds. The methacrylated alginate resulted in more stable beads and cells were viable following encapsulation. Alginate microbeads, ionic (unmodified) and dual crosslinked, were implanted into a rat omentum pouch model. Implantation was performed with a local injection of 100 µl of 50 µg/ml of Lipopolysaccharide (LPS) to stimulate a robust inflammatory challenge in vivo. Implants were retrieved at 1 and 3 weeks for analysis. The unmodified alginate microbeads had all failed by week 1, whereas the dual-crosslinked alginate microbeads remained stable up through 3 weeks. The modified alginate microbeads may provide a more stable alternative to current alginate-based systems for cell encapsulation. STATEMENT OF SIGNIFICANCE: Alginate, a naturally occurring polysaccharide, has been used for cell encapsulation to prevent graft rejection of cell transplants for people with type I diabetes. Although some success has been observed in clinical trials, the lack of reproducibility and failure to reach insulin dependence for longer periods of time indicates the need for improvements in the procedure. A major requirement for the long-term function of alginate encapsulated cells is the mechanical stability of microcapsules. Insufficient mechanical integrity of the capsules can lead to immunological reactions in the recipients. In this work, alginate was modified to allow photoactivatable groups in order to allow formation of covalent crosslinks in addition to ionic crosslinking. The dual crosslinking design prevents capsule breakdown following implantation in vivo.

Indexed as

MicrospheresAlginatesAnimalsCross-Linking ReagentsHydrogelsInflammationLipopolysaccharidesMaleMethacrylatesModels, AnimalOmentumRatsRats, Sprague-DawleyUltraviolet Rays2-aminoethylmethacrylateAlginatesCross-Linking ReagentsHydrogelsLipopolysaccharidesMethacrylatesAlginateInflammationMethacrylated alginateMicrobeadsOmentum

Identifiers

PMID29101016
PMCPMC5902406
OpenAlexW2766904613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.